ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Andrew Maitland
Paul W.M. Fedak
Vivek Rao
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ko, L.
Right arrow Articles by Verma, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ko, L.
Right arrow Articles by Verma, S.
Related Collections
Right arrow Coronary disease

Ann Thorac Surg 2002;73:1185-1188
© 2002 The Society of Thoracic Surgeons


Original article: cardiovascular

Endothelin blockade potentiates endothelial protective effects of ace inhibitors in saphenous veins

Lawrence Ko, BSa, Andrew Maitland, MDa, Paul W.M. Fedak, MDa, Aaron S. Dumont, MDa, Mitesh Badiwala, BSa, Fina Lovren, PhDa, Christopher R. Triggle, PhDa, Todd J. Anderson, MDa, Vivek Rao, MD, PhDa, Subodh Verma, MD, PhD*a

a Division of Cardiac Surgery, The University of Toronto, Toronto General Hospital, Toronto, Ontario, and Division of Cardiac Surgery, The University of Calgary, Calgary, Alberta, Canada

* Address reprint requests to Dr Verma, Division of Cardiac Surgery, The University of Toronto, Toronto General Hospital, 200 Elizabeth St, 14th Floor, Eaton Wing EN 14-217, Toronto, ON M5G 2C4, Canada
e-mail: subodh.verma{at}sympatico.ca

Presented at the Poster Session of the Thirty-seventh Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 29–31, 2001.

Background. Angiotensin II and endothelin-1 are potent endothelium-derived contracting factors. The effects of acute endothelin antagonism on endothelial function in saphenous vein from patients treated with and without angiotensin-converting enzyme inhibitors were compared.

Methods. Vascular segments of saphenous vein were obtained perioperatively from 14 patients on angiotensin-converting enzyme inhibitors and 29 controls. In vitro endothelium-dependent and -independent responses to acetylcholine and sodium nitroprusside were assessed by constructing isometric dose-response curves in precontracted rings in the presence and absence of bosentan (endothelinA/B receptor antagonist) and BQ-123 (endothelinA antagonist) using isolated organ baths. Percent maximum relaxation and sensitivity were compared between interventions.

Results. Endothelium-dependent relaxation to acetylcholine was augmented in the angiotensin-converting enzyme inhibitor-treated group (p < 0.005). Both specific and mixed endothelin receptor blockade improved acetylcholine-mediated relaxation in the angiotensin-converting enzyme inhibitor-treated and untreated groups (p < 0.02). The effects of these antagonists were endothelium specific as endothelium-independent responses to sodium nitroprusside remain unaltered.

Conclusions. These data demonstrate that (1) chronic angiotensin-converting enzyme inhibition improves endothelial function in saphenous veins, and (2) this effect can be further augmented by acute endothelin blockade. These data suggest that antagonism of both angiotensin II and endothelin may be important in attenuating saphenous vein arteriosclerosis.




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
F. Bohm and J. Pernow
The importance of endothelin-1 for vascular dysfunction in cardiovascular disease
Cardiovasc Res, October 1, 2007; 76(1): 8 - 18.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
N. Dhaun, J. Goddard, and DavidJ. Webb
The Endothelin System and Its Antagonism in Chronic Kidney Disease
J. Am. Soc. Nephrol., April 1, 2006; 17(4): 943 - 955.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The Society of Thoracic Surgeons.